Rheumatology
RA, lupus, vasculitis, gout, biologics.
Polyarteritis nodosa
Kawasaki disease
Viral Arthritis
Transition of Adolescents with Rheumatic Disease
Cryoglobulinaemia
IgA vasculitis
ANCA-associated vasculitides
Takayasu arteritis
Giant cell arteritis
Systemic vasculitides overview
Psoriatic arthritis
Enteropathic arthritis
Reactive arthritis
Axial spondyloarthritis
Spondyloarthritis — overview
Raynaud phenomenon
Pregnancy-related low back pain and pelvic girdle pain
Polymyalgia rheumatica
Transient synovitis of the hip
Traction apophysitis
Slipped upper femoral epiphysis
Perthes disease
Diffuse amplified musculoskeletal pain syndromes
Developmental dysplasia of the hip
Benign nocturnal limb pain in children
Chronic exertional compartment syndrome
Musculoskeletal conditions in children — overview
Prepatellar bursitis
Osteoarthritis
Whiplash-associated disorder
Cervical radiculopathy
Cervical myelopathy
Rheumatoid Arthritis
Cervical myelopathy
Nonspecific neck pain
Neck pain — overview
Plantar fasciitis
Australian clinical guidelines for the diagnosis and management of plantar fasciitis
Complete Achilles tendon tear
Australian clinical guidelines for the diagnosis and management of complete Achilles tendon rupture
Medial tibial stress syndrome
Australian clinical guidelines for the diagnosis and management of medial tibial stress syndrome (shin splints)
Patellofemoral pain syndrome
Evidence-based management of patellofemoral pain syndrome in Australian general practice, including physiotherapy, patellar taping, foot orthoses, and activity modification.
Degenerative meniscal tears
Australian clinical guideline for the management of degenerative meniscal tears including the role of physiotherapy versus surgery, investigations, and long-term osteoarthritis prevention.
Acute knee injuries
Australian clinical guideline for the assessment and management of acute knee injuries including ACL rupture, meniscal tears, collateral ligament sprains, patellar dislocation, and tibial plateau fracture.
Greater trochanteric pain syndrome
Clinical guideline for greater trochanteric pain syndrome (gluteal tendinopathy) — diagnosis, load management, physiotherapy, corticosteroid injection, and management in Australian general practice.
Lower limb conditions
Clinical overview of lower limb musculoskeletal conditions including hip, knee, leg, ankle and foot disorders — diagnosis, management, and referral in Australian general practice.
Trigger finger and flexor tenosynovitis
Australian GP guideline for diagnosis and management of trigger finger and stenosing flexor tenosynovitis, including corticosteroid injection, splinting, and A1 pulley release.
Carpal tunnel syndrome
Australian GP guideline for the diagnosis and management of carpal tunnel syndrome, including splinting, corticosteroid injection, nerve conduction studies, and surgical decompression.
De Quervain tenosynovitis
Australian clinical guidelines for De Quervain tenosynovitis: diagnosis with Finkelstein's test, corticosteroid injection into the first dorsal compartment, EPB subcompartment targeting, splinting, and surgical release.
Epicondylar tendinopathy
Australian clinical guidelines for epicondylar tendinopathy (tennis elbow and golfer's elbow): diagnosis, physiotherapy loading programs, corticosteroid injection, PRP, and surgical management.
Adhesive capsulitis (frozen shoulder)
Australian clinical guidelines for adhesive capsulitis (frozen shoulder) covering diagnosis, phase-appropriate management, corticosteroid injection, hydrodilatation, and physiotherapy.
Upper limb conditions
Australian clinical guidelines for upper limb musculoskeletal conditions covering assessment of shoulder, elbow, wrist, and hand pain with investigation and management pathways.
JIA-associated uveitis
Australian clinical guidelines for JIA-associated uveitis covering screening protocols, risk stratification, topical and systemic therapy including adalimumab, and long-term monitoring.
Enthesitis-related arthritis
Australian clinical guidelines for enthesitis-related arthritis (ERA): HLA-B27, sacroiliitis, TNF inhibitor therapy, and transition to ankylosing spondylitis.
Systemic juvenile idiopathic arthritis
Australian clinical guidelines for systemic juvenile idiopathic arthritis (sJIA): diagnosis, MAS recognition, IL-1/IL-6 targeted therapy, and GP management.
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis
Australian clinical guidelines for RF-negative polyarticular juvenile idiopathic arthritis, including diagnosis, treatment with methotrexate and biologics, uveitis surveillance, and management in Australian paediatric rheumatology practice.
Oligoarticular juvenile idiopathic arthritis
Australian clinical guidelines for oligoarticular juvenile idiopathic arthritis (oligoarticular JIA), including diagnosis, uveitis screening and management, intra-articular corticosteroid injection, systemic treatment, and follow-up in Australian primary care and paediatric rheumatology practice.
Juvenile idiopathic arthritis — overview
Australian clinical guidelines for juvenile idiopathic arthritis (JIA) — overview of all seven ILAR subtypes including oligoarticular, polyarticular, systemic JIA, ERA, and psoriatic JIA with management and uveitis surveillance.
ANCA-associated vasculitis
Australian clinical guidelines for ANCA-associated vasculitis (GPA, MPA, EGPA) — induction with rituximab or cyclophosphamide, maintenance therapy, and organ-specific management.
Giant cell arteritis and polymyalgia rheumatica
Australian clinical guidelines for giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) — diagnosis, steroid dosing, tocilizumab, visual loss prevention, and monitoring.
Mixed connective tissue disease
Australian clinical guidelines for mixed connective tissue disease (MCTD), covering overlap features, anti-U1 RNP, PAH surveillance, and organ-based management.
Systemic sclerosis
Australian clinical guidelines for systemic sclerosis (scleroderma), covering limited and diffuse cutaneous subtypes, organ manifestations, immunosuppression, and monitoring.
Sjögren syndrome
Australian clinical guidelines for primary and secondary Sjögren syndrome — sicca management, extraglandular disease, lymphoma surveillance, and pharmacological treatment.
SLE in children and adolescents
Paediatric systemic lupus erythematosus — Australian clinical guidelines covering diagnosis, classification, pharmacological management, monitoring, special populations, and transition to adult care.
Systemic lupus erythematosus (SLE) in adults
Australian clinical guideline for systemic lupus erythematosus (SLE) in adults — diagnosis, lupus nephritis, immunosuppression, monitoring, and pregnancy management.
Inflammatory connective tissue diseases
Australian clinical guideline overview of inflammatory connective tissue diseases including SLE, systemic sclerosis, Sjögren syndrome, myositis, MCTD, and overlap syndromes.
Immunoglobulin G4-related disease
Australian clinical guideline on IgG4-related disease including diagnosis, organ manifestations, glucocorticoid treatment, and steroid-sparing management.
Juvenile Dermatomyositis
Australian guideline on juvenile dermatomyositis including diagnosis, MSA-defined subtypes, calcinosis prevention, and management in children.
Adult Dermatomyositis
Australian GP guideline on the diagnosis and management of adult dermatomyositis, including MSA-defined subtypes, malignancy screening, ILD management, and skin disease.
Idiopathic Inflammatory Myopathies
Australian GP guideline on the diagnosis and management of idiopathic inflammatory myopathies (IIM), including dermatomyositis, polymyositis, IMNM, and anti-synthetase syndrome.
Fibromyalgia
Australian GP guideline on the diagnosis and management of fibromyalgia, including central sensitisation mechanisms, exercise and psychological therapy, and appropriate pharmacological adjuncts.
Calcium pyrophosphate deposition disease
Australian GP guideline on the diagnosis and management of calcium pyrophosphate deposition (CPPD) disease, including acute CPP crystal arthritis, chronic CPPD, and investigation for secondary metabolic causes.
Asymptomatic hyperuricaemia
Australian GP guideline on the assessment and management of asymptomatic hyperuricaemia, including risk stratification, lifestyle modification, and when to consider urate-lowering therapy.